Hilotherapy for Prevention of Chemotherapy-induced Peripheral Polyneuropathy
ConditionEquipment and Supplies
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Ulm
About this trial
Prospective study of hilotherapy of hands and feet as prevention of chemotherapy-induced peripheral polyneuropathy induced by Taxan-based chemotherapy regimen that are used in the therapy of breast cancer and genital malignoma of the women.
Eligibility criteria
Qualifiers
Written consent for participation in this trail
Age ≥18 years
Female
Breast or genital cancer of the woman
Disqualifiers
pre-existing peripheral polyneuropathy
chemotherapy with taxan- and/or carboplatin-based regimens in a preceding therapy
Existence of one of the following diseases: Diabetes mellitus (of any type), neurological diseases that are involving peripheral nerve damage (e.g. Multiple Sclerosis, Amytrophic lateral sclerosis, Parkinson's disease), chronic pain syndrome, Cryoglobulinemia, cold hemagglutination, cold hives / cold contact hives, Raynaud's disease, significant peripheral artery disease,
Lack of knowledge of German
Trial design
Treatments tested in this trial
- Hilotherm ChemoCare
Treatment groups
150 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Ulm
Lead sponsor
Hilotherm
Collaborator
Source ClinicalTrials.gov